ARCHIVES

Study Of Tamoxifen And Raloxifene Enrolls 6,000 In First Year; 5 Percent Are Minorities

This article is from The Cancer Letter archive.

Vol. 23 No. 7 | July 28, 2000

Download PDF Visit The Full Archive

Related Articles

CALGB Chairman Schilsky To Step Down After 15 Years Leading Cooperative Group.

February 1, 2008

New Cancer Control Projects Aimed At Upgrading Care At Community Level; 56 Contracts Anticipated

November 15, 1974

FDA Approves Gleevec For First Line Rx Of CML

January 31, 2003

House Appropriations by Institute

July 8, 1994

In Brief: MB Withdraws From Fight Over Funding New Constructions, Tosses The Ball To Ted Cooper

January 9, 1976

Health Reform Bill Contains Unpleasant Surprises For Drug Manufacturers

November 5, 1993